Anticorps Monoclonal anti-IgG2a Isotype Control
IgG2a Isotype Control Monoclonal Antibody for FC
Hôte / Isotype
Mouse / IgG2a, kappa
Réactivité testée
Applications
FC
Conjugaison
PE Fluorescent Dye
CloneNo.
C1.18.4
N° de cat : PE-65208
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en cytométrie |
Dilution recommandée
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
FC | See 2 publications below |
Informations sur le produit
PE-65208 cible IgG2a Isotype Control dans les applications de FC et montre une réactivité avec des échantillons
Réactivité | |
Hôte / Isotype | Mouse / IgG2a, kappa |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | s/o |
Nom complet | IgG2a Isotype Control |
Symbole du gène | |
Identification du gène (NCBI) | |
Conjugaison | PE Fluorescent Dye |
Excitation/Emission maxima wavelengths | 496 nm, 565 nm / 578 nm |
Forme | Liquide |
Méthode de purification | Purification par affinité |
Tampon de stockage | PBS with 0.09% sodium azide and 0.5% BSA. |
Conditions de stockage | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Informations générales
The C1.18.4 immunoglobulin is useful as an isotype-matched control. The C.1.18.4 immunolglobulin has an unknown binding specificity and is used as an isotype control for mouse IgG2a antibodies. This antibody has been quality-tested for flow cytometry as negative control.
Protocole
Product Specific Protocols | |
---|---|
FC protocol for PE IgG2a Isotype Control antibody PE-65208 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nat Microbiol Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions | ||
Oncol Rep MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β‑catenin pathway. |